Tzeng Ching-Wei D, Smith J Kevin, Heslin Martin J
Section of Surgical Oncology, Department of Surgery, 301 Kracke Building, 1922 7th Avenue South, University of Alabama-Birmingham, Birmingham, AL 35294, USA.
Surg Oncol Clin N Am. 2007 Apr;16(2):389-402. doi: 10.1016/j.soc.2007.03.006.
Soft tissue sarcoma (STS) management requires accurate tumor imaging for staging, treatment planning, and clinical follow-up. Careful preoperative planning may prevent poor primary resections that place the patient at risk for more operations, local recurrence, and worse survival. Although MRI may be preferred for extremity STS, contrast-enhanced CT is an excellent alternative, with no decrease in ability to plan the operative strategy for limb-sparing resection. In retroperitoneal and other intra-abdominal STS, double (oral/intravenous) contrast-enhanced CT evaluates for liver metastases, defines surrounding vital structures that might be resected en bloc, identifies margins at risk for local recurrence, and shows surrounding organs at risk for toxicity during radiation therapy. Postoperative clinical follow-up and imaging must continue even beyond 5 years because of the continued risk of long-term relapse.
软组织肉瘤(STS)的管理需要精确的肿瘤成像,用于分期、治疗规划和临床随访。仔细的术前规划可以避免不理想的初次切除,从而降低患者接受更多手术、局部复发以及生存预后变差的风险。虽然对于肢体STS,MRI可能是首选,但增强CT是一种很好的替代方法,在制定保肢切除手术策略的能力方面并无下降。对于腹膜后和其他腹腔内STS,双重(口服/静脉)增强CT可评估肝转移情况,界定可能整块切除的周围重要结构,识别有局部复发风险的边缘,并显示放疗期间有中毒风险的周围器官。由于长期复发风险持续存在,术后临床随访和成像甚至必须持续超过5年。